Xylazine - Medical and Public Health Imperatives.  Gupta R, Holtgrave DR, Ashburn MA.  N Engl J Med. 2023 Apr 26. doi: 10.1056/NEJMp2303120. Epub ahead of print. PMID: 37099338. https://www.nejm.org/doi/full/10.1056/NEJMp2303120

Drug Information Detailed, evidence-based information on drugs and their properties, applications, effects and risks. Based on the latest pharmacological research. (drugscience.org, UK, Stand 20.04.2023) https://www.drugscience.org.uk/drug-informa…

UK. RADAR Alert 2023/04, Nitazene type drugs in Scotland There is an increase in the availability of a new type of synthetic opioid called nitrazenes. Due to their unexpected presence they pose a substantial risk of overdose, hospitalisation and de…

Internationale Studie bestätigt langfristige Sicherheit von Methylphenidat bei Kindern und Jugendlichen mit ADHS Ein internationales Forscherteam hat festgestellt, dass das am häufigsten verschriebene Medikament zur Behandlung der Aufmerksamkeitsde…

Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: A longitudinal study Chan, Adrienne Y.L. et al. eClinicalMedicine, Volume 0, Issue 0, 101780  https://www.thelancet.com/journ…

Xylazine: What Does the Emergence of this New Contaminant Mean for People Who Use Drugs and Health Care Providers? Throughout the past year, a substance called xylazine has been saturating the drug supply in many parts of the United States. Xylazin…